{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:44Z","timestamp":1790612204791,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":395,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jacc.2019.05.043","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T15:43:46Z","timestamp":1563810226000},"page":"512-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia"],"prefix":"10.1016","volume":"74","author":[{"given":"Mark","family":"Trinder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Liza","family":"DeCastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luba","family":"Cermakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh","family":"Sadananda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawmid","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B. John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Frohlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam R.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.05.043_bib1","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.05.043_bib2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib3","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jacc.2019.05.043_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.05.043_bib5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehx004","article-title":"Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia","volume":"38","author":"Tada","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.05.043_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2019.05.043_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/humu.9264","article-title":"Molecular characterization of familial hypercholesterolemia in Spain: Identification of 39 novel and 77 recurrent mutations in LDLR","volume":"24","author":"Mozas","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2019.05.043_bib8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib9","first-page":"574","article-title":"Improving the yield of genetic testing in familial hypercholesterolaemia","volume":"38","author":"Ajufo","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.05.043_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.12.001","article-title":"The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population","volume":"180","author":"Damgaard","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.05.043_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2015.08.033","article-title":"Clinical features of familial hypercholesterolemia in Korea: predictors of pathogenic mutations and coronary artery disease\u2014a study supported by the Korean Society of Lipidology and Atherosclerosis","volume":"243","author":"Shin","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.05.043_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/heartjnl-2012-302917","article-title":"Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia","volume":"99","author":"Clarke","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2019.05.043_bib13","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2019.05.043_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.05.043_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2019.05.043_bib16","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2019.05.043_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and risk of cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.05.043_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2019.05.043_bib19","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-018-05747-8","article-title":"Deep-coverage whole genome sequences and blood lipids among 16,324 individuals","volume":"9","author":"Natarajan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2019.05.043_bib20","first-page":"385","article-title":"Contemporary trends in the management and outcomes of patients with familial hypercholesterolemia in Canada: a prospective observational study","volume":"33","author":"Brunham","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1373\/clinchem.2005.055228","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia","volume":"51","author":"Holmes","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2019.05.043_bib22","first-page":"326","article-title":"The British Columbia Familial Hypercholesterolemia Registry","volume":"55","author":"Wong","year":"2013","journal-title":"B\u00a0C Med J"},{"key":"10.1016\/j.jacc.2019.05.043_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.05.043_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1185\/030079903125002405","article-title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","volume":"19","author":"McKenney","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacc.2019.05.043_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"De Backer","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.05.043_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/clc.22959","article-title":"The design and rationale of SAVE BC: The Study to Avoid Vascular Events in British Columbia","volume":"41","author":"Brunham","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.05.043_bib28","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1194\/jlr.P058891","article-title":"Targeted next-generation sequencing to diagnose disorders of HDL cholesterol","volume":"56","author":"Sadananda","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2019.05.043_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1164\/rccm.201806-1157OC","article-title":"Cholesteryl ester transfer protein influences high-density lipoprotein levels and survival in sepsis","volume":"199","author":"Trinder","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2019.05.043_bib30","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacc.2019.05.043_bib31","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1194\/jlr.D079301","article-title":"Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia","volume":"58","author":"Iacocca","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2019.05.043_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOL.0000000000000496","article-title":"Familial hypercholesterolemia: experience from France","volume":"29","author":"Rab\u00e8s","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2019.05.043_bib34","doi-asserted-by":"crossref","first-page":"E682","DOI":"10.1002\/humu.21002","article-title":"The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2019.05.043_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2017.05.015","article-title":"Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia","volume":"263","author":"Sharifi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.05.043_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOL.0000000000000397","article-title":"Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns","volume":"28","author":"Hopkins","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2019.05.043_bib37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41431-017-0078-y","article-title":"Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?","volume":"26","author":"Ghaleb","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacc.2019.05.043_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib39","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does\u00a0it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.05.043_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.05.043_bib41","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.05.043_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2017.04.002","article-title":"Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry","volume":"262","author":"Bourbon","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2019.05.043_bib43","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1177\/2047487317708890","article-title":"New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials","volume":"24","author":"Ellis","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2019.05.043_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.05.043_bib45","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.05.043_bib46","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child\u2013parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2019.05.043_bib47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.5551\/jat.37770","article-title":"Frequency of Achilles tendon xanthoma in patients with acute coronary syndrome","volume":"24","author":"Harada","year":"2017","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jacc.2019.05.043_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1194\/jlr.D400030-JLR200","article-title":"Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia","volume":"46","author":"Wang","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacc.2019.05.043_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOL.0000000000000483","article-title":"Role of DNA copy number variation in dyslipidemias","volume":"29","author":"Iacocca","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacc.2019.05.043_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-0004.2009.01168.x","article-title":"Multiplex ligation-dependent probe amplification analysis to screen for deletions and duplications of the LDLR gene in patients with familial hypercholesterolaemia","volume":"76","author":"Taylor","year":"2009","journal-title":"Clin Genet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719353781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719353781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:23:48Z","timestamp":1760016228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719353781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0735109719353781"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.05.043","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.05.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}